Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment as Usual Care Group”

7 trials

Showing 7 of 7 results

Not applicableStudy completedNCT02019823
What this trial is testing

Effectiveness of SMS-text Message Support for Patients With Hypertension to Improve Blood Pressure

Who this might be right for
HypertensionSMS-textmHealth
University of Oxford 1,372
Large-scale testing (Phase 3)Study completedNCT00776984
What this trial is testing

Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II)

Who this might be right for
Asthma
Boehringer Ingelheim 453
Not applicableStudy completedNCT04445155
What this trial is testing

The DECIDE Parent-Provider Intervention

Who this might be right for
Modified DECIDE InterventionTreatment as Usual Care Group
Indiana University 89
Not applicableStudy completedNCT01484223
What this trial is testing

Effectiveness of Cognitive Behavioral Intervention in Patients With Symptoms Somatization in Primary Care

Who this might be right for
Quality of Life
Gerencia de Atención Primaria, Madrid 242
Large-scale testing (Phase 3)Study completedNCT01634152
What this trial is testing

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Who this might be right for
Asthma
Boehringer Ingelheim 401
Large-scale testing (Phase 3)Study completedNCT00772538
What this trial is testing

Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I)

Who this might be right for
Asthma
Boehringer Ingelheim 459
Large-scale testing (Phase 3)Study completedNCT01277523
What this trial is testing

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Who this might be right for
Asthma
Boehringer Ingelheim 392

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation